Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like Teikoku, State AGs Reach Agreement to End Pay-For-Delay for Lidoderm Patches February 1, 2018 Senators Request Tri-Source Justify 1,400 Percent Price Hikes for Cancer Drug April 3, 2018 Incyte Gets Complete Response Letter for Jakafi Extended-Release Tablets March 26, 2023